Gradalis Inc. Announces Presentation Of New Data
6/18/2014 9:09:41 AM
DALLAS, June 18, 2014 (GLOBE NEWSWIRE) -- Gradalis Inc., a late-stage oncology therapeutic company, today announced that new data from its lead cancer programs focused on its personalized immunotherapy product were presented in May 2014 at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) and the 17th Annual meeting of the American Society of Gene and Cellular Therapy (ASGCT).
Help employers find you! Check out all the jobs and post your resume.
comments powered by